DE60328814D1 - Hm1.24 verwertende krebsvakzine - Google Patents

Hm1.24 verwertende krebsvakzine

Info

Publication number
DE60328814D1
DE60328814D1 DE60328814T DE60328814T DE60328814D1 DE 60328814 D1 DE60328814 D1 DE 60328814D1 DE 60328814 T DE60328814 T DE 60328814T DE 60328814 T DE60328814 T DE 60328814T DE 60328814 D1 DE60328814 D1 DE 60328814D1
Authority
DE
Germany
Prior art keywords
cancer vaccine
protein
valuable
valuable cancer
transduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60328814T
Other languages
English (en)
Inventor
Yong Kwee
Masaaki Kosaka
Yasuo Koishihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
Chugai Pharmaceutical Co Ltd
Original Assignee
University College London
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London, Chugai Pharmaceutical Co Ltd filed Critical University College London
Application granted granted Critical
Publication of DE60328814D1 publication Critical patent/DE60328814D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/57—Skin; melanoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE60328814T 2002-10-30 2003-10-30 Hm1.24 verwertende krebsvakzine Expired - Lifetime DE60328814D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002316639 2002-10-30
PCT/JP2003/013954 WO2004039398A1 (en) 2002-10-30 2003-10-30 Hm1.24-utilizing cancer vaccines

Publications (1)

Publication Number Publication Date
DE60328814D1 true DE60328814D1 (de) 2009-09-24

Family

ID=32211691

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60328814T Expired - Lifetime DE60328814D1 (de) 2002-10-30 2003-10-30 Hm1.24 verwertende krebsvakzine

Country Status (7)

Country Link
US (1) US8652839B2 (de)
EP (1) EP1559432B1 (de)
JP (1) JP4716730B2 (de)
AT (1) ATE439143T1 (de)
AU (1) AU2003278603A1 (de)
DE (1) DE60328814D1 (de)
WO (1) WO2004039398A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080219974A1 (en) * 2002-03-01 2008-09-11 Bernett Matthew J Optimized antibodies that target hm1.24
WO2005034994A1 (ja) * 2003-10-10 2005-04-21 Chugai Seiyaku Kabushiki Kaisha 固形腫瘍治療剤
JP2006141208A (ja) * 2004-11-16 2006-06-08 Univ Of Tokushima 多発性骨髄腫、白血病、悪性リンパ腫、肺癌等の免疫療法剤
US8329186B2 (en) 2004-12-20 2012-12-11 Isu Abxis Co., Ltd Treatment of inflammation using BST2 inhibitor
JP5562031B2 (ja) 2006-09-18 2014-07-30 ゼンコー・インコーポレイテッド Ｈｍ１．２４を標的とする最適化抗体
EP2281579A1 (de) 2009-08-05 2011-02-09 BioNTech AG Impfstoffzusammensetzung mit 5'-Cap-modifizierter RNA
CN107541513B (zh) * 2016-06-28 2020-11-17 深圳宾德生物技术有限公司 用于沉默cd317的小分子干扰rna、重组载体、药物及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043703A1 (fr) * 1998-02-25 1999-09-02 Chugai Seiyaku Kabushiki Kaisha Technique de dosage immunochimique de l'anticorps anti-hm1.24
AU2001246846A1 (en) 2000-04-06 2001-10-23 Chugai Seiyaku Kabushiki Kaisha Immunoassay of anti-hm1.24 antibody
ATE317428T1 (de) * 2001-01-15 2006-02-15 Idm Immuno Designed Molecules Verfahren zur herstellung von submikropartikel- suspensionen pharmazeutischer substanzen

Also Published As

Publication number Publication date
AU2003278603A8 (en) 2004-05-25
EP1559432B1 (de) 2009-08-12
US8652839B2 (en) 2014-02-18
EP1559432A4 (de) 2006-05-17
US20060153883A1 (en) 2006-07-13
ATE439143T1 (de) 2009-08-15
AU2003278603A1 (en) 2004-05-25
JP4716730B2 (ja) 2011-07-06
WO2004039398A1 (en) 2004-05-13
EP1559432A1 (de) 2005-08-03
JP2006508094A (ja) 2006-03-09

Similar Documents

Publication Publication Date Title
NO20020348D0 (no) Peptid acceptor ligeringsmetoder
ATE342917T1 (de) Antimikrobielle polypeptide aus pseudoplectania nigrella
WO2004024757A3 (en) Modified pna molecules
EP2500429A3 (de) RNAi zur Kontrolle von Insekten und Spinnen
CY1112735T1 (el) Πολυπεπτιδια δυναμενα εκμαιευσης μιας ανοσιακης αντιδρασης εναντι του καρκινου
WO2003093296A3 (en) Kinase anchor protein muteins, peptides thereof, and related methods
BR0209989A (pt) Plataformas baseadas em cromossomas
DK1471926T3 (da) Sammensætninger og fremgangsmåder til terapeutisk anvendelse af en atonal-associeret sekvens
WO2005003315A3 (en) Compositions and methods for peptide-assisted transfection
DE60328814D1 (de) Hm1.24 verwertende krebsvakzine
CY1116649T1 (el) Τεχνητη dna αλληλουχια με βελτιστοποιημενη λειτουργια οδηγου σε 5' (5-utr) για βελτιωμενη εκφραση ετερολογων πρωτεϊνων σε φυτα
DK1344827T3 (da) Frostbeskyttende proteiner fra basidiomycetes
AU2002361951A1 (en) Genes of corynebacterium glutamicum encoding for genetic stability, gene expression and folding proteins
TW200510460A (en) Antimicrobial polypeptides
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
BR0316224A (pt) Sequência de dna da região genÈmica tcd de photorhabdus luminescens
TW200502253A (en) Antimicrobial polypeptides
ATE469171T1 (de) Neue insektizide proteine von bazillus thuringiensis
ATE442441T1 (de) Virale expressionsvektoren für pflanzen
BR0309526A (pt) Metiltiofenocarboxanilidas
WO2003047532A3 (en) Compositions and methods for the therapeutic use of an atonal-associated sequence for a gastrointestinal condition
ATE414905T1 (de) Diabetesmodell
AU2003282465A8 (en) Isolated mammalian membrane protein genes
DE602004023311D1 (de) Antigen-zufuhrsystem
PT1537210E (pt) Inibicao de oliconucleotidos decoy de expressao cd-40

Legal Events

Date Code Title Description
8364 No opposition during term of opposition